This event has concluded, but exciting conferences are happening worldwide — explore upcoming events in your field and stay ahead with the latest insights and networking opportunities. Subscribe to our newsletter.

Gene Therapy Analytical Development 2023

120 120 people viewed this event.

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.

Time: 8:00 AM – 5:00 PM

Venue details: Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States

Prices: USD 3199.00 – USD 6195.00

Speakers: Adam Washburn, Director, Research and Development, Eli Lilly, Akshata Ijantkar, Senior Principal Scientist and CMC Team Lead, Gene and Cell Therapy Programs, Bristol Myers Squibb, Allison Schorzman, Scientist II, BridgeBio Gene Therapy,  and more

Event Organizer - Hanson Wade

Event Website
 

Date

27–30 November 2023
 

City

 

Country

United States of America
 

Topic Area

Health and Medicine

Share With Colleagues